Article
A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population.
Journal of clinical pharmacy and therapeutics - 1 Oct 2021
Zhu Jia, Liu Wenpei, Zhang Meiling, Lu Lihuan, Pan Hongqiu, He Xiaomin, Wang Nannan, Yang Miaomiao, Yi Honggang, Tang Shaowen
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: Anti-tuberculosis (anti-TB) drug-induced hepatotoxicity (ATDH) is a serious adverse drug reaction. A recent study found that the rs2011404 variant of uridine 5'-diphospho-glucuronosyl-transferase 1A4 (UGT1A4) is a marker of susceptibility to ATDH. The present study aimed to validate this relationship in an Eastern Chinese Han anti-TB treatment population. METHODS: A 1:4 matched...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
